Sabra Healthcare REIT (SBRA) Stock Forecast & Price Target

Compare

1,071 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

SBRA Analyst Ratings

Moderate Buy

2 Buy

3 Hold

0 Sell

Based on 5 analysts giving stock ratings to

Sabra

Healthcare REIT

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

SBRA Stock 12 Month Forecast

Average Price Target

$19.20

▲(5.21%Upside)

Based on 5 Wall Street analysts offering 12 month price targets for Sabra Healthcare REIT in the last 3 months. The average price target is $19.20 with a high forecast of $20.00 and a low forecast of $18.00. The average price target represents a 5.21% change from the last price of $18.25.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"$12","21":"$21","14.25":"$14.25","16.5":"$16.5","18.75":"$18.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":20,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$20.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":19.2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$19.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$18.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,14.25,16.5,18.75,21],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.48,17.673846153846153,17.86769230769231,18.06153846153846,18.255384615384617,18.44923076923077,18.643076923076922,18.836923076923078,19.03076923076923,19.224615384615383,19.41846153846154,19.61230769230769,19.806153846153848,{"y":20,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.48,17.61230769230769,17.744615384615386,17.876923076923077,18.00923076923077,18.141538461538463,18.273846153846154,18.406153846153845,18.538461538461537,18.67076923076923,18.803076923076922,18.935384615384613,19.067692307692308,{"y":19.2,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.48,17.52,17.56,17.6,17.64,17.68,17.72,17.76,17.8,17.84,17.88,17.92,17.96,{"y":18,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":13.59,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.36,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.06,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.18,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.64,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.7,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.73,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.72,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.13,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.33,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.2,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.32,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.48,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$20.00

Average Price Target$19.20

Lowest Price Target$18.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$21

Buy

15.07%

Upside

Reiterated

06/13/25

Sabra Healthcare REIT shows strong financial performance with improving profitability and robust cash flow. Technical indicators suggest bullish momentum, although the stock's high P/E ratio indicates it may be overvalued. Positive earnings call highlights and strategic corporate events contribute to a favorable outlook, despite some external challenges.

Unknown AnalystWells Fargo

Not Ranked

Wells Fargo

$20

Buy

9.59%

Upside

Reiterated

06/17/25

Sabra Healthcare REIT (SBRA) Receives a Buy from Wells Fargo

Michael LewisTruist Financial

Truist Financial

$18

Hold

-1.37%

Downside

Reiterated

05/15/25

Truist Financial Remains a Hold on Sabra Healthcare REIT (SBRA)

Nicholas YulicoScotiabank

Scotiabank

$18→$19

Hold

4.11%

Upside

Reiterated

05/12/25

Sabra Health Care price target raised to $19 from $18 at ScotiabankSabra Health Care price target raised to $19 from $18 at Scotiabank

Juan C. SanabriaBMO Capital

BMO Capital

$19

Hold

4.11%

Upside

Reiterated

05/05/25

Hold Rating on Sabra Healthcare REIT Amid Strong Financials and Strategic Uncertainties

Jeffrey SpectorBank of America Securities

Bank of America Securities

$21→$20

Buy

9.59%

Upside

Reiterated

04/14/25

Sabra Health Care price target lowered to $20 from $21 at BofASabra Health Care price target lowered to $20 from $21 at BofA

Austin WurschmidtKeyBanc

KeyBanc

―

Hold

―

Reiterated

02/25/25

KeyBanc Sticks to Their Hold Rating for Sabra Healthcare REIT (SBRA)

Aaron HechtCitizens JMP

Citizens JMP

$20

Buy

9.59%

Upside

Reiterated

02/21/25

JMP Securities Sticks to Their Buy Rating for Sabra Healthcare REIT (SBRA)

Joe DicksteinJefferies

Jefferies

$20

Buy

9.59%

Upside

Assigned

01/01/25

Sabra Health Care price target lowered to $20 from $21 at JefferiesSabra Health Care price target lowered to $20 from $21 at Jefferies

Vikram MalhotraMizuho Securities

Mizuho Securities

$20

Hold

9.59%

Upside

Downgraded

12/05/24

Sabra Health Care downgraded to Neutral from Outperform at MizuhoSabra Health Care downgraded to Neutral from Outperform at Mizuho

Dave RodgersRobert W. Baird

Robert W. Baird

$16→$18

Hold

-1.37%

Downside

Reiterated

11/14/24

Sabra Healthcare REIT Inc. (SBRA) PT Raised to $18 at BairdBaird analyst David Rodgers raised the price target on Sabra Healthcare REIT Inc. (NASDAQ: SBRA) to $18.00 (from $16.00) while maintaining a Neutral rating.

Nicholas JosephCiti

Citi

$17→$20

Buy

9.59%

Upside

Upgraded

09/12/24

Sabra Health Care upgraded to Buy from Neutral at CitiSabra Health Care upgraded to Buy from Neutral at Citi

Omotayo OkusanyaDeutsche Bank

Deutsche Bank

$21

Buy

15.07%

Upside

Reiterated

08/07/24

Sabra Healthcare REIT: A Strong Buy on Robust Financial Performance and Growth Prospects

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$21

Buy

15.07%

Upside

Reiterated

06/13/25

Unknown AnalystWells Fargo

Not Ranked

Wells Fargo

$20

Buy

9.59%

Upside

Reiterated

06/17/25

Sabra Healthcare REIT (SBRA) Receives a Buy from Wells Fargo

Michael LewisTruist Financial

Truist Financial

$18

Hold

-1.37%

Downside

Reiterated

05/15/25

Truist Financial Remains a Hold on Sabra Healthcare REIT (SBRA)

Nicholas YulicoScotiabank

Scotiabank

$18→$19

Hold

4.11%

Upside

Reiterated

05/12/25

Sabra Health Care price target raised to $19 from $18 at ScotiabankSabra Health Care price target raised to $19 from $18 at Scotiabank

Juan C. SanabriaBMO Capital

BMO Capital

$19

Hold

4.11%

Upside

Reiterated

05/05/25

Hold Rating on Sabra Healthcare REIT Amid Strong Financials and Strategic Uncertainties

Jeffrey SpectorBank of America Securities

Bank of America Securities

$21→$20

Buy

9.59%

Upside

Reiterated

04/14/25

Sabra Health Care price target lowered to $20 from $21 at BofASabra Health Care price target lowered to $20 from $21 at BofA

Austin WurschmidtKeyBanc

KeyBanc

―

Hold

―

Reiterated

02/25/25

KeyBanc Sticks to Their Hold Rating for Sabra Healthcare REIT (SBRA)

Aaron HechtCitizens JMP

Citizens JMP

$20

Buy

9.59%

Upside

Reiterated

02/21/25

JMP Securities Sticks to Their Buy Rating for Sabra Healthcare REIT (SBRA)

Joe DicksteinJefferies

Jefferies

$20

Buy

9.59%

Upside

Assigned

01/01/25

Sabra Health Care price target lowered to $20 from $21 at JefferiesSabra Health Care price target lowered to $20 from $21 at Jefferies

Vikram MalhotraMizuho Securities

Mizuho Securities

$20

Hold

9.59%

Upside

Downgraded

12/05/24

Sabra Health Care downgraded to Neutral from Outperform at MizuhoSabra Health Care downgraded to Neutral from Outperform at Mizuho

Dave RodgersRobert W. Baird

Robert W. Baird

$16→$18

Hold

-1.37%

Downside

Reiterated

11/14/24

Nicholas JosephCiti

Citi

$17→$20

Buy

9.59%

Upside

Upgraded

09/12/24

Sabra Health Care upgraded to Buy from Neutral at CitiSabra Health Care upgraded to Buy from Neutral at Citi

Omotayo OkusanyaDeutsche Bank

Deutsche Bank

$21

Buy

15.07%

Upside

Reiterated

08/07/24

Sabra Healthcare REIT: A Strong Buy on Robust Financial Performance and Growth Prospects

Stocks with the Highest Top Analyst Consensus in the Real Estate Sector

xxx

Find stocks in the Real Estate sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sabra Healthcare REIT

1 Month

xxx

Success Rate

4/8 ratings generated profit

Average Return

+2.43%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +2.43% per trade.

3 Months

xxx

Success Rate

3/4 ratings generated profit

Average Return

+3.60%

assigned a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +3.60% per trade.

1 Year

Joe DicksteinJefferies

Success Rate

4/4 ratings generated profit

Average Return

+22.23%

assigned a buy rating 6 months ago

Copying Joe Dickstein's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +22.23% per trade.

2 Years

xxx

Success Rate

4/4 ratings generated profit

Average Return

+24.88%

assigned a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +24.88% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SBRA Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, SBRA has received 2 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. SBRA average Analyst price target in the past 3 months is 19.20.

Each month's total comprises the sum of three months' worth of ratings.

SBRA Financial Forecast

SBRA Earnings Forecast

Next quarter’s earnings estimate for SBRA is $0.17 with a range of $0.17 to $0.18. The previous quarter’s EPS was $0.17. SBRA beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.28% of the time in the same period. In the last calendar year SBRA has Outperformed its overall industry.

SBRA Sales Forecast

Next quarter’s sales forecast for SBRA is $181.94M with a range of $174.60M to $185.99M. The previous quarter’s sales results were $185.53M. SBRA beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 71.66% of the time in the same period. In the last calendar year SBRA has Outperformed its overall industry.

SBRA Stock Forecast FAQ

What is SBRA’s average 12-month price target, according to analysts?

Based on analyst ratings, Sabra Healthcare REIT’s 12-month average price target is 19.20.

What is SBRA’s upside potential, based on the analysts’ average price target?

Sabra Healthcare REIT has 5.21% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is SBRA a Buy, Sell or Hold?

Sabra Healthcare REIT has a consensus rating of Moderate Buy which is based on 2 buy ratings, 3 hold ratings and 0 sell ratings.

What is Sabra Healthcare REIT’s price target?

The average price target for Sabra Healthcare REIT is 19.20. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $20.00 ,the lowest forecast is $18.00. The average price target represents 5.21% Increase from the current price of $18.25.

What do analysts say about Sabra Healthcare REIT?

Sabra Healthcare REIT’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 5 Wall Streets Analysts.

How can I buy shares of SBRA?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Sabra Healthcare REIT (SBRA) Stock Forecast & Price Target

SBRA Analyst Ratings

SBRA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Sabra Healthcare REIT

SBRA Analyst Recommendation Trends

SBRA Financial Forecast

SBRA Earnings Forecast

SBRA Sales Forecast

SBRA Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts